CDER Gains Agency-Wide Functions Under Commissioner Office Restructuring
This article was originally published in The Tan Sheet
Executive Summary
FDA's Center for Drug Evaluation & Research gains several agency-wide functions under the Office of the Commissioner restructuring that took effect June 20.